These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18983337)

  • 41. The metabolic syndrome and schizophrenia.
    Meyer JM; Stahl SM
    Acta Psychiatr Scand; 2009 Jan; 119(1):4-14. PubMed ID: 19133915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.
    Ren J; Kelley RO
    Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of glucose homeostasis on protein metabolism in patients with advanced chronic kidney disease.
    Ikizler TA
    J Ren Nutr; 2007 Jan; 17(1):13-6. PubMed ID: 17198926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Associations of the limb fat to trunk fat ratio with markers of cardiometabolic risk in elderly men and women.
    Saunders TJ; Davidson LE; Janiszewski PM; Després JP; Hudson R; Ross R
    J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1066-70. PubMed ID: 19561143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic syndrome and periodontitis: is oxidative stress a common link?
    Bullon P; Morillo JM; Ramirez-Tortosa MC; Quiles JL; Newman HN; Battino M
    J Dent Res; 2009 Jun; 88(6):503-18. PubMed ID: 19587154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High sensitivity C-reactive protein is associated with the metabolic syndrome independent to viral and bacterial pathogen burden.
    Ebrahimi A; Nabipour I; Vahdat K; Jafari SM; Fouladvand M; Assadi M; Movahed A; Obeidi N; Sanjdideh Z
    Diabetes Res Clin Pract; 2009 Jun; 84(3):296-302. PubMed ID: 19362745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women.
    Gaspard U
    Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The metabolic syndrome: a gathering challenge in a time of abundance.
    Bricker LA; Greydanus DE
    Adolesc Med State Art Rev; 2008 Dec; 19(3):475-97, ix. PubMed ID: 19227387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin resistance in chronic uremia.
    Guarnieri G; Zanetti M; Vinci P; Cattin MR; Barazzoni R
    J Ren Nutr; 2009 Jan; 19(1):20-4. PubMed ID: 19121765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications.
    Craft S
    Alzheimer Dis Assoc Disord; 2006; 20(4):298-301. PubMed ID: 17132977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multifactorial intervention in metabolic syndrome targeting at prevention of chronic kidney disease--ready for prime time?
    Korantzopoulos P; Elisaf M; Milionis HJ
    Nephrol Dial Transplant; 2007 Oct; 22(10):2768-74. PubMed ID: 17673497
    [No Abstract]   [Full Text] [Related]  

  • 52. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
    Yamauchi T; Kadowaki T
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
    Younossi ZM; McCullough AJ
    Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperlipidaemia and cardiovascular disease: nonfasting triglycerides gain momentum--but nothing changes on the metabolic syndrome front.
    Dominiczak MH
    Curr Opin Lipidol; 2008 Jun; 19(3):326-7. PubMed ID: 18460927
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
    Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
    Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Polycystic ovary syndrome and insulin resistance].
    Puder J; Pralong F
    Rev Med Suisse; 2009 Apr; 5(198):779-82. PubMed ID: 19418980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The metabolic syndrome and the risk of arterial and venous thrombosis.
    Franchini M; Targher G; Montagnana M; Lippi G
    Thromb Res; 2008; 122(6):727-35. PubMed ID: 17996282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic syndrome-From human organ disease to laminar failure in equids.
    Geor R; Frank N
    Vet Immunol Immunopathol; 2009 Jun; 129(3-4):151-4. PubMed ID: 19110319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CVD risk assessment: do we need the metabolic syndrome or better global cardiometabolic risk calculators?
    Després JP
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S1-4. PubMed ID: 18469833
    [No Abstract]   [Full Text] [Related]  

  • 60. Serum and intracellular magnesium deficiency in patients with metabolic syndrome--evidences for its relation to insulin resistance.
    Lima Mde L; Cruz T; Rodrigues LE; Bomfim O; Melo J; Correia R; Porto M; Cedro A; Vicente E
    Diabetes Res Clin Pract; 2009 Feb; 83(2):257-62. PubMed ID: 19124169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.